The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.876
Bid: 0.876
Ask: 0.878
Change: -0.004 (-0.45%)
Spread: 0.002 (0.228%)
Open: 0.882
High: 0.882
Low: 0.876
Prev. Close: 0.88
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Dec 2017 07:00

RNS Number : 2713A
BioPharma Credit PLC
27 December 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

BioPharma Credit PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Issue of New Shares

Yes

3. Full name of person(s) subject to thenotification obligation: iii

Inteligo Bank Ltd.

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

18 December 2017

6. Date on which issuer notified:

21 December 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

8%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD USD0.01

Below 9%

Below 9%

78,525,801

78,525,801

0

8.59%

0.0%

GB00BDGKMY29

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

 

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

78,525,801

8.59%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Victor Vinatea / Guillermo Villanueva

15. Contact telephone number:

+507-366-9602 / +507-366-9670

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUVORBRAUUAA
Date   Source Headline
13th May 202411:40 amRNSDirector/PDMR Shareholding
10th May 20243:11 pmRNSSTATEMENT RE COHERUS BIOSCIENCES, INC.
8th May 20243:52 pmRNSHolding(s) in Company
7th May 20246:15 pmRNSTransaction in Own Shares
3rd May 20246:15 pmRNSTransaction in Own Shares
2nd May 20246:15 pmRNSTransaction in Own Shares
2nd May 202412:18 pmRNSNEW INVESTMENT OF UP TO US$400 MILLION
1st May 202410:25 amRNSTotal Voting Rights
30th Apr 20246:15 pmRNSTransaction in Own Shares
29th Apr 20246:15 pmRNSTransaction in Own Shares
26th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20246:15 pmRNSTransaction in Own Shares
24th Apr 20247:00 amRNSNEW INVESTMENT OF UP TO US$100 MILLION
23rd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20246:15 pmRNSTransaction in Own Shares
22nd Apr 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:15 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSNotice of AGM
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:15 pmRNSTransaction in Own Shares
15th Apr 20246:15 pmRNSTransaction in Own Shares
12th Apr 20246:15 pmRNSTransaction in Own Shares
11th Apr 20246:15 pmRNSTransaction in Own Shares
10th Apr 20246:15 pmRNSTransaction in Own Shares
9th Apr 20246:15 pmRNSTransaction in Own Shares
8th Apr 20246:15 pmRNSTransaction in Own Shares
4th Apr 20246:15 pmRNSTransaction in Own Shares
3rd Apr 20246:15 pmRNSTransaction in Own Shares
2nd Apr 20246:15 pmRNSTransaction in Own Shares
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
27th Mar 20247:01 amRNSUPDATES TO THE DISCOUNT CONTROL MECHANISM
27th Mar 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
25th Mar 202411:35 amRNSDirector/PDMR Shareholding
21st Mar 20244:05 pmRNSDividend Declaration
21st Mar 20244:00 pmRNSNet Asset Value(s)
15th Mar 20244:35 pmRNSUPDATE ON INVESTMENT
11th Mar 20244:00 pmRNSNet Asset Value(s) and Monthly Factsheet
1st Mar 20243:10 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSNotice of Full Year Results
26th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20246:15 pmRNSTransaction in Own Shares
19th Feb 20246:15 pmRNSTransaction in Own Shares
16th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20246:15 pmRNSTransaction in Own Shares
13th Feb 20247:00 amRNSSTATEMENT RE IMMUNOGEN, INC.
9th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20246:15 pmRNSTransaction in Own Shares
8th Feb 20247:00 amRNSDividend Declaration
7th Feb 20246:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.